Zenflow

Medical device for enlarged prostate

LOCATION South San Francisco, CA

COMPANY SIZE Between 5 and 10

# OF ENGINEERS Less than 5

FUNDING $2M - $5M

REMOTE WORK OK? No

EXTENDED EXERCISE WINDOW? No

TAGS Medical Devices, Health Care, YC Winter 2015

What do we do?

We've created the Spring device, an novel therapy to treat urinary obstruction related to BPH (enlarged prostate). This condition affects 90% of men by age 80 and has a major impact on quality of life. Our device will provide immediate and permanent symptom relief in an easy 10-minute office-based procedure. We've achieved very positive animal data and will begin human trials in early 2016. With the easiest, safest, and most cost-effective BPH therapy, we have unique potential to address tens of millions patients worldwide each year.

Why join us?

1) Innovative new technology that could help tens of millions of people each year
2) Our culture is more like a YC startup than your typical medical device company
3) We move fast, lean, and smart

Technical challenges

Developing implant and delivery system for human use

Our tech stack

  • nitinol

Our investors

  • Golden Seeds
  • Paul Buchheit
  • Astia Angels
  • Paul Graham
  • Zod Nazem
  • Dorm Room Fund
  • Varsity Ventures
  • Joyo Wijaya
  • Roger Bamford
  • Max Schireson
  • Stanford-StartX Fund
  • Gil Seton
  • SV Tech Ventures
  • Y Combinator